North America Umbilical Cord Blood Banking Market

The North America umbilical cord blood banking market was valued at US$ 1,023.99 million in 2023 and is expected to reach US$ 2,272.47 million by 2031; it is estimated to record a CAGR of 10.5% from 2023 to 2031.

Rising Prevalence of Chronic Illnesses Fuels North America Umbilical Cord Blood Banking Market

The rising geriatric population and unhealthy lifestyle contribute to the increasing prevalence of chronic diseases, propelling the demand for alternative and potentially curative treatment options. Umbilical cord blood, rich in hematopoietic stem cells, offers a valuable option for treating various conditions, including blood cancers, autoimmune diseases, and genetic disorders. There are rising advancements in stem cell research and the increasing success rates of cord blood transplants in treating a more comprehensive range of diseases. The realization that a child's cord blood can provide a potentially life-saving resource for themselves or a family member is a powerful motivator for parents. Thus, families are increasingly opting to preserve their child's cord blood, recognizing its potential therapeutic value for future use in case of a medical need, particularly in the face of escalating chronic illness rates. Therefore, the growing need for stem cell-based therapies due to the rising prevalence of chronic illnesses fuels the North America umbilical cord blood banking market growth.

North America Umbilical Cord Blood Banking Market Overview

In North America, the US holds the largest share of the umbilical cord blood banking market. The increasing utilization of regenerative medicines for disease management and growing emphasis on lowering hospitalizations and healthcare costs drive the growth of the US market. The healthcare sector in the US is witnessing massive investments in accelerating research and development activities in umbilical cord blood banking. The first Fund of NYBC Ventures was established in 2023 with the objective of advancing innovation in the blood-related sectors, cellular medicines, and supporting technologies. New York Blood Center, Inc. (NYBC) committed US$50 million to the Fund. NYBC Ventures, an early-stage life sciences investment firm, will focus on providing capital for innovative devices, technologies, and treatments that address the most pressing issues in benign hematology, transfusion medicine, and infectious illness. The fund also seeks to improve patient outcomes through the creation of treatments, supporting platforms and technologies, and strategic alliances to broaden the impact of NYBC. These activities boost organic developments such as product launches, product approvals, and new product innovations. Increasing financial aid by investors, government authorities, and significant players fuels the US umbilical cord blood banking market growth.

North America Umbilical Cord Blood Banking Market Revenue and Forecast to 2031 (US$ Million)

North America Umbilical Cord Blood Banking Strategic Insights

Strategic insights for the North America Umbilical Cord Blood Banking provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Umbilical Cord Blood Banking Report Scope

North America Umbilical Cord Blood Banking Regional Insights

The geographic scope of the North America Umbilical Cord Blood Banking refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

North America Umbilical Cord Blood Banking Market Segmentation 

The North America umbilical cord blood banking market is segmented into bank type, service, end user, and country.

Based on bank type, the North America umbilical cord blood banking market is bifurcated into public and private. The public segment held a larger market share in 2023.

In terms of service, the North America umbilical cord blood banking market is bifurcated into storage and processing. The storage segment held a larger market share in 2023.

By end user, the North America umbilical cord blood banking market is segmented into hospitals, research institutes, and others. The hospitals segment held the largest market share in 2023.

By country, the North America umbilical cord blood banking market is segmented into the US, Canada, and Mexico. The US dominated the North America umbilical cord blood banking market share in 2023.

AlphaCord, LLC; HÉMA-QUÉBEC; NovaCord; Revvity Inc; and WMDA are some of the leading companies operating in the North America umbilical cord blood banking market.